K06620                      KO                                     

transcription factor E2F3
ko01522  Endocrine resistance
ko04110  Cell cycle
ko04218  Cellular senescence
ko04934  Cushing's syndrome
ko05161  Hepatitis B
ko05166  HTLV-I infection
ko05167  Kaposi's sarcoma-associated herpesvirus infection
ko05200  Pathways in cancer
ko05206  MicroRNAs in cancer
ko05212  Pancreatic cancer
ko05214  Glioma
ko05215  Prostate cancer
ko05218  Melanoma
ko05219  Bladder cancer
ko05220  Chronic myeloid leukemia
ko05222  Small cell lung cancer
ko05223  Non-small cell lung cancer
ko05224  Breast cancer
ko05225  Hepatocellular carcinoma
ko05226  Gastric cancer
M00692  Cell cycle - G1/S transition
KEGG Orthology (KO) [BR:ko00001]
 Cellular Processes
  Cell growth and death
   04110 Cell cycle
    K06620  E2F3; transcription factor E2F3
   04218 Cellular senescence
    K06620  E2F3; transcription factor E2F3
 Human Diseases
   05200 Pathways in cancer
    K06620  E2F3; transcription factor E2F3
   05206 MicroRNAs in cancer
    K06620  E2F3; transcription factor E2F3
   05212 Pancreatic cancer
    K06620  E2F3; transcription factor E2F3
   05225 Hepatocellular carcinoma
    K06620  E2F3; transcription factor E2F3
   05226 Gastric cancer
    K06620  E2F3; transcription factor E2F3
   05214 Glioma
    K06620  E2F3; transcription factor E2F3
   05220 Chronic myeloid leukemia
    K06620  E2F3; transcription factor E2F3
   05218 Melanoma
    K06620  E2F3; transcription factor E2F3
   05219 Bladder cancer
    K06620  E2F3; transcription factor E2F3
   05215 Prostate cancer
    K06620  E2F3; transcription factor E2F3
   05224 Breast cancer
    K06620  E2F3; transcription factor E2F3
   05222 Small cell lung cancer
    K06620  E2F3; transcription factor E2F3
   05223 Non-small cell lung cancer
    K06620  E2F3; transcription factor E2F3
  Endocrine and metabolic diseases
   04934 Cushing's syndrome
    K06620  E2F3; transcription factor E2F3
  Infectious diseases
   05166 HTLV-I infection
    K06620  E2F3; transcription factor E2F3
   05161 Hepatitis B
    K06620  E2F3; transcription factor E2F3
   05167 Kaposi's sarcoma-associated herpesvirus infection
    K06620  E2F3; transcription factor E2F3
  Drug resistance
   01522 Endocrine resistance
    K06620  E2F3; transcription factor E2F3
KEGG modules [BR:ko00002]
 Functional set
  Cellular processes
   Cell signaling
    M00692  Cell cycle - G1/S transition
     K06620  E2F3; transcription factor E2F3
Transcription factors [BR:ko03000]
 Eukaryotic Type
   Fork head/winged helix cell cycle-controlling factors, E2F
    K06620  E2F3; transcription factor E2F3
BRITE hierarchy
HSA: 1871(E2F3)
PTR: 471865(E2F3)
PPS: 100986032(E2F3)
GGO: 101138211(E2F3)
PON: 100448297(E2F3)
NLE: 100594018(E2F3)
MCC: 713904(E2F3)
MCF: 102138138(E2F3)
CSAB: 103222084(E2F3)
RRO: 104654803(E2F3)
RBB: 108522131(E2F3)
CJC: 100390235(E2F3)
SBQ: 101034207(E2F3)
MMU: 13557(E2f3)
RNO: 291105(E2f3)
CGE: 100754647(E2f3)
NGI: 103745641(E2f3)
HGL: 101698963(E2f3)
CCAN: 109697329(E2f3)
OCU: 100353173(E2F3)
TUP: 102499416(E2F3)
CFA: 488239(E2F3)
AML: 100484544(E2F3)
UMR: 103678383(E2F3)
ORO: 101371945(E2F3)
FCA: 101089768(E2F3)
PTG: 102948948(E2F3)
AJU: 106987605(E2F3)
BTA: 541184(E2F3)
BOM: 102270876(E2F3)
BIU: 109577245(E2F3)
PHD: 102324622(E2F3)
CHX: 102169535(E2F3)
OAS: 101121809(E2F3)
SSC: 100154407(E2F3)
CFR: 102513737(E2F3)
CDK: 105089193(E2F3)
BACU: 103007760(E2F3)
LVE: 103085882(E2F3)
OOR: 101269392(E2F3)
ECB: 100052248(E2F3)
EPZ: 103549781(E2F3)
EAI: 106847694(E2F3)
MYB: 102259711(E2F3)
MYD: 102768307(E2F3)
HAI: 109381623(E2F3)
RSS: 109448706(E2F3)
PALE: 102887239(E2F3)
LAV: 100656140(E2F3)
TMU: 101346679
MDO: 100017977(E2F3)
SHR: 100934669(E2F3)
OAA: 100090475(E2F3)
GGA: 420824(E2F3)
MGP: 100549000
CJO: 107309724(E2F3)
APLA: 101793883(E2F3)
ACYG: 106041729(E2F3)
TGU: 100218382(E2F3)
GFR: 102039591(E2F3)
FAB: 101815458(E2F3)
PHI: 102099157(E2F3)
PMAJ: 107200762(E2F3)
CCW: 104691435(E2F3)
FPG: 101918557(E2F3)
FCH: 102046119(E2F3)
CLV: 102089870(E2F3)
EGZ: 104125451(E2F3)
AAM: 106500319(E2F3)
ASN: 102387519(E2F3)
AMJ: 102560678(E2F3)
PSS: 102446755(E2F3)
CMY: 102933240(E2F3)
CPIC: 101939961(E2F3)
ACS: 100551868(e2f3)
PVT: 110072925(E2F3)
PBI: 103055302(E2F3)
GJA: 107121911(E2F3)
XLA: 108719151(e2f3.L) 398159(e2f3.S)
XTR: 496522(e2f3)
NPR: 108786389(E2F3)
DRE: 791146(e2f3)
IPU: 108272398 108275414(e2f3)
AMEX: 103022559 103038273(e2f3)
TRU: 101079212(e2f3) 105417145
LCO: 104920190(e2f3) 104936242
NCC: 104941105(e2f3)
MZE: 101464453(e2f3) 101479374
OLA: 101154792 101158132(e2f3)
XMA: 102227367(e2f3) 102238348
PRET: 103472053 103478383(e2f3)
NFU: 107374299 107378737(e2f3)
CSEM: 103388290(e2f3) 103394109
LCF: 108889207(e2f3) 108900426
HCQ: 109517659(e2f3) 109519227
BPEC: 110167309 110171730(e2f3)
ELS: 105007462(e2f3) 105030233
LCM: 102355481(E2F3)
CMK: 103184907(e2f3)
CIN: 778584(e2f1/2/3/6)
SPU: 762571(E2E3)
APLC: 110978256
DME: Dmel_CG6376(E2f1)
DSI: Dsimw501_GD19970(Dsim_GD19970)
MDE: 101899368
AAG: 5576834
TUT: 107368690
MYI: 110465804
OBI: 106883944
LAK: 106175980
ADF: 107344047
AQU: 100636697
ATH: AT1G47870(ATE2F2) AT2G36010(E2F3) AT5G22220(E2F1)
LJA: Lj1g3v2156580.2(Lj1g3v2156580.2) Lj3g3v2949670.1(Lj3g3v2949670.1) Lj3g3v2949670.2(Lj3g3v2949670.2) Lj5g3v0816340.1(Lj5g3v0816340.1)
DOSA: Os02t0537500-01(Os02g0537500) Os04t0112200-00(Os04g0112200) Os04t0416100-01(Os04g0416100) Os12t0158800-01(Os12g0158800)
ATS: 109732644(LOC109732644) 109753167(LOC109753167) 109763537(LOC109763537) 109768933(LOC109768933)
VCN: VOLCADRAFT_127253(e2f1)
DDI: DDB_G0284129(E2F)
DFA: DFA_08107
SPAR: SPRG_02714
 » show all
Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K
The retinoblastoma protein binds to a family of E2F transcription factors.
Mol Cell Biol 13:7813-25 (1993)

DBGET integrated database retrieval system